Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bezafibrate in PBC Patients with Suboptimal Response to UDCA
NCT02937012Phase 3Unknown
- Sponsor
- Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán
- Start
- Oct 2016
- Primary completion
- Apr 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in primary biliary cholangitis (PBC) comparing Bezafibrate + UDCA with Placebo + UDCA (2 arms). Primary endpoint: Complete biochemical response at 12 months. Status: unknown.
02
Drugs
bezafibrate
03
Conditions
primary biliary cholangitis (PBC)
Beyond the preview
Go deeper on NCT02937012.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02937012.